1,10-phenanthroline has been researched along with Leukemia, T-Cell in 1 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, HG | 1 |
| Fok, KS | 1 |
| Fendly, BM | 1 |
| Chiang, NY | 1 |
| Sussman, HH | 1 |
1 other study available for 1,10-phenanthroline and Leukemia, T-Cell
| Article | Year |
|---|---|
Activation of TNF-R1 receptor in the presence of copper kills TNF resistant CEM leukemic T cells.
Topics: Animals; Cell Line; Cell Survival; Copper; Drug Synergism; Flow Cytometry; Hydrogen-Ion Concentratio | 1994 |